Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization



Status:Terminated
Conditions:Liver Cancer, Cancer, Gastrointestinal
Therapuetic Areas:Gastroenterology, Oncology
Healthy:No
Age Range:18 - Any
Updated:4/17/2018
Start Date:October 25, 2012
End Date:April 3, 2017

Use our guide to learn which trials are right for you!

Pilot Study of Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization

The successful localization of the y90 microspheres by PET/MR and/or PET/CT scans would be a
useful tool in individualizing patient care after the radioembolization procedure. The
information from a PET/MR or PET/CT scan would allow for early evaluation of the technical
success of the procedure.


Inclusion Criteria:

- Participant must successfully complete the MRI screening form if receiving an MRI

- Participant must be scheduled to undergo radioembolization for any indication

- Participant must be ≥ 18 years of age

- Participant must be able to understand and willing to sign an Institutional Review
Board (IRB)-approved written informed consent document

Exclusion Criteria:

- Participant must not have any contraindications to MRI scanning

- Patient must not be pregnant or breastfeeding

- If agreeing to MRI contrast, participant must not have renal insufficiency (glomerular
filtration rate (GFR < 30 mL/min/1.73 m2) measured within the past 60 days

- If agreeing to MRI contrast, participant must not be on dialysis

- If agreeing to MRI contrast, participant must not have had a prior allergic reaction
to gadolinium-based contrast agents

- PET/MRI or PET/CT is not able to be scheduled within 72 hours of radioembolization
We found this trial at
1
site
660 S Euclid Ave
Saint Louis, Missouri 63110
(314) 362-5000
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials